Mr Ede continues to serve on Mindray’s board of directors but does not serve on any of the board’s committees. Ms Hsu will immediately begin working closely with Mr Ede in the transition period between now and May 1, 2009, when Mr Ede takes on the CFO role. Ms Hsu will remain available in an advisory capacity after Mr Ede takes the CFO position.
Staying on as a director, Ms Hsu will replace Mr Ede on the compensation committee and the nominations and corporate governance committee of Mindray’s board.
Mr Ede has served as a director on Mindray’s board since the company’s initial public offering in September 2006. Mr Ede has received his bachelor degree in business administration from the University of Hawaii, and an MBA from the University of Washington.
Xu Hang, chairman and co-CEO of Mindray, said: “Ms Hsu has been instrumental in positioning Mindray as an internationally recognized, value-driven medical device company. On behalf of the board of directors and Mindray, I want to personally thank Joyce for her tremendous contributions to the company over the past several years.”